Glaxosmi. Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,732.50
17.85 (0.66%)
BSENSE

Nov 20

BSE+NSE Vol: 95.11 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 793005,
    "name": "Glaxosmi. Pharma",
    "stock_name": "Glaxosmi. Pharma",
    "full_name": "Glaxosmithkline Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/glaxosmi-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,732.50",
    "chg": 17.85,
    "chgp": "0.66%",
    "dir": 1,
    "prev_price": "2,714.65",
    "mcapval": "45,893.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 500660,
    "symbol": "GLAXO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE159A01016",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "95.11 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/glaxosmi-pharma-793005-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd Downgraded to Hold Amid Mixed Technical and Valuation Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/glaxosmithkline-pharmaceuticals-ltd-downgraded-to-hold-amid-mixed-technical-and-valuation-signals-4264851",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/Glaxosmithkline_mojoScore_4264851.png",
        "date": "2026-11-17 09:03:20",
        "description": "Glaxosmithkline Pharmaceuticals Ltd has seen its investment rating downgraded from Buy to Hold as of 16 Nov 2026, reflecting a nuanced shift in its technical outlook and valuation metrics despite strong financial performance and management efficiency. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced this decision, providing investors with a comprehensive understanding of the stock’s current standing."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd is Rated Buy",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/glaxosmithkline-pharmaceuticals-ltd-is-rated-buy-4262369",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/Glaxosmithkline_mojoScore_4262369.png",
        "date": "2026-11-15 10:10:29",
        "description": "Glaxosmithkline Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 11 November 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 15 November 2026, providing investors with the most up-to-date view of the company’s fundamentals and market performance."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Gains 5.73%: 4 Key Technical Shifts Driving the Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-gains-573-4-key-technical-shifts-driving-the-week-4261875",
        "imagepath": "",
        "date": "2026-11-14 15:02:45",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>09 Nov:</strong> Intraday high with 5.65% surge to Rs.2,688.30</p>\n                    <p><strong>11 Nov:</strong> Shift to mildly bullish momentum with 6.77% gain closing at Rs.2,710.85</p>\n                    <p><strong>12 Nov:</strong> Technical momentum upgraded to bullish, closing at Rs.2,726.40</p>\n                    <p><strong>13 Nov:</strong> Mildly bullish trend amid mixed indicators, closing at Rs.2,655.30</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.2,524.85</div>\n                    </div>..."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicators",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicators-4260026",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/Glaxosmithkline_technicaldot_4260026.png",
        "date": "2026-11-13 08:03:59",
        "description": "Glaxosmithkline Pharmaceuticals Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of mid-November 2026. Despite a recent day decline of 2.61%, the stock’s broader technical indicators reveal a complex interplay of bullish and bearish signals, reflecting a cautious market sentiment amid sectoral and macroeconomic factors."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd Surges 5.65% to Day's High of Rs 2688.3 — Outperforms Sector by 3.92 Percentage Points",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-ltd-hits-intraday-high-with-565-surge-4256854",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/Glaxosmithkline_priceRelatedfactors_4256854.png",
        "date": "2026-11-09 10:21:46",
        "description": "The Sensex declined 0.22% on 09 Nov 2026 while Glaxosmithkline Pharmaceuticals Ltd surged 5.65%, outperforming its sector by nearly 4 percentage points. This strong single-session gain stands out as a stock-specific event amid a broadly weaker market, signalling a noteworthy shift in short-term momentum."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Gains 1.66%: Mixed Technical Signals Shape Weekly Performance",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-gains-166-mixed-technical-signals-shape-weekly-performance-4255505",
        "imagepath": "",
        "date": "2026-11-07 15:05:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Nov:</strong> Stock opens strong at Rs.2,528.35 (+1.80%) amid positive market sentiment</p>\n                    <p><strong>3 Nov:</strong> Mojo Grade upgraded to Hold; stock rises to Rs.2,573.30 (+1.78%)</p>\n                    <p><strong>4 Nov:</strong> Technical momentum shifts to sideways; stock dips to Rs.2,532.60 (-1.58%)</p>\n                    <p><strong>5 Nov:</strong> Daily moving averages turn mildly bullish despite price decline to Rs.2,500.70 (-1.26%)</p>\n                    <p><strong>6 Nov:</strong> Stock rebounds to Rs.2,524.85 (+0.97%) closing the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><..."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicators",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicators-4251419",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/Glaxosmithkline_technicaldot_4251419.png",
        "date": "2026-11-05 08:04:27",
        "description": "Glaxosmithkline Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance despite mixed signals from key indicators. The stock’s recent downgrade from a Sell to a Hold rating by MarketsMOJO reflects this evolving technical landscape, as investors weigh the implications of fluctuating momentum against broader market conditions."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Gains 3.27%: 4 Key Factors Driving the Week",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-gains-327-4-key-factors-driving-the-week-4245902",
        "imagepath": "",
        "date": "2026-10-31 16:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>26 Oct:</strong> Stock opens strong at ₹2,448.15 with a 1.80% gain</p>\n                    <p><strong>27 Oct:</strong> Technical momentum shifts amid mixed signals; stock rises 1.66%</p>\n                    <p><strong>29 Oct:</strong> Technical momentum turns mildly bearish despite a 0.32% gain</p>\n                    <p><strong>30 Oct:</strong> MarketsMOJO upgrades rating to Hold; stock closes at ₹2,483.55 (-1.28%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.2,404.80</div>\n                    </div>\n..."
      },
      {
        "title": "Glaxosmithkline Pharmaceuticals Ltd Technical Momentum Shifts to Mildly Bullish",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/glaxosmithkline-pharmaceuticals-ltd-technical-momentum-shifts-to-mildly-bullish-4243912",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/Glaxosmithkline_technicaldot_4243912.png",
        "date": "2026-10-30 08:01:52",
        "description": "Glaxosmithkline Pharmaceuticals Ltd has recently exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish trend. This change is underscored by a combination of mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting a nuanced market sentiment for the mid-cap pharmaceutical player."
      }
    ],
    "total": 76,
    "sid": "793005",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/glaxosmithkline-pharmaceuticals-793005"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "18-Nov-2026",
      "details": "As per attachment",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Notice of Postal Ballot",
      "datetime": "17-Nov-2026",
      "details": "Postal Ballot Notice for approval of Related Party Transactions",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "08-Nov-2026",
      "details": "As per attachment",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Glaxosmithkline Pharmaceuticals Ltd has declared <strong>570%</strong> dividend, ex-date: 29 May 26",
          "dt": "2026-05-29",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Glaxosmithkline Pharmaceuticals Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 11 Sep 18",
          "dt": "2018-09-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

18-Nov-2026 | Source : BSE

As per attachment

Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

17-Nov-2026 | Source : BSE

Postal Ballot Notice for approval of Related Party Transactions

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

08-Nov-2026 | Source : BSE

As per attachment

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Glaxosmithkline Pharmaceuticals Ltd has declared 570% dividend, ex-date: 29 May 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Glaxosmithkline Pharmaceuticals Ltd has announced 1:1 bonus issue, ex-date: 11 Sep 18

stock-summary
RIGHTS

No Rights history available